The BSI’s original ethos – to disseminate research with the aim of promoting and advancing immunology to foster future innovation – still lies at the heart of our organisation. We’re proud to achieve this through the publication of our two official journals, Immunology and Clinical & Experimental Immunology. Profits derived from the sale of the journals are invested back into the BSI, providing major financial support for the Society's charitable activities, including our grant schemes, careers programme and public engagement activities.
The Plan S initiative for Open Access publishing was launched in September 2018 with the aim that, from 2020, scientific publications that result from research funded by public grants must be published in compliant Open Access journals or platforms. The plan is supported by cOAlition S, an international consortium of research funders.
The British Society for Immunology has been working with the Society Publishers’ Coalition, a group of not-for-profit learned societies, membership charities and community publishers, to ensure the voice of small organisations such as ours are heard in the upcoming discussions on this. As a group, we support the principles of open scholarship and believe that open access to research outputs will benefit researchers across our shared communities. With a global author base, we believe that authors must be able to publish in our journals regardless of their funding status or ability to pay. However, we also believe that the transition to full open scholarship must be managed in a sustainable, inclusive way to ensure the future system is fit for purpose for all stakeholders. The Society Publishers’ Coalition has released our joint response to the Plan S consultation detailing our position on this issue and how we would like to engage with cOAlition S to bring about a future where sustainable open access publishing is accessible to all.
If you have any queries, please contact the BSI’s Head of Publishing, Lucy McIvor.